| Dr Ioannis Papayannis, MD | |
|
4800 S Hazel St, Pine Bluff, AR 71603-6860 | |
| (870) 534-5533 | |
| (870) 534-5535 |
| Full Name | Dr Ioannis Papayannis |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 4800 S Hazel St, Pine Bluff, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013250554 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 320796 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ochsner Lsu Health Shreveport | Shreveport, LA | Hospital |
| Ochsner Lsu Health Monroe | Monroe, LA | Hospital |
| Kearney Regional Medical Center | Kearney, NE | Hospital |
| Ochsner Lsu Health Shreveport-st Mary Medical Cent | Shreveport, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lsu Health Sciences Center Shreveport Faculty Group Practice | 4082902721 | 529 |
News Archive
Smokeless tobacco and, more recently, e-cigarettes have been promoted as a harm reduction strategy for smokers who are "unable or unwilling to quit."
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
An ultrafast, 320-detector computed tomography scanner that shows both anatomy within coronary arteries and blood flow can accurately sort out which people need - or don't need - an invasive procedure to identify coronary blockages, according to an international study. The researchers say their findings could potentially save millions of people worldwide from having an unnecessary cardiac catheterization.
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its levonorgestrel and ethinyl estradiol (0.10 mg/0.02 mg) oral contraceptive product prior to the expiration of U.S. Patent No. 7,615,545, which is owned by Duramed Pharmaceuticals, Inc., a subsidiary of Teva Pharmaceutical Industries, Ltd.
There are fears in the UK that people who are vulnerable to flu infections may well have to wait for their annual injection this season.
› Verified 3 days ago
| Entity Name | Lsu Health Sciences Center Shreveport Faculty Group Practice |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013374222 PECOS PAC ID: 4082902721 Enrollment ID: O20161012000307 |
News Archive
Smokeless tobacco and, more recently, e-cigarettes have been promoted as a harm reduction strategy for smokers who are "unable or unwilling to quit."
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
An ultrafast, 320-detector computed tomography scanner that shows both anatomy within coronary arteries and blood flow can accurately sort out which people need - or don't need - an invasive procedure to identify coronary blockages, according to an international study. The researchers say their findings could potentially save millions of people worldwide from having an unnecessary cardiac catheterization.
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its levonorgestrel and ethinyl estradiol (0.10 mg/0.02 mg) oral contraceptive product prior to the expiration of U.S. Patent No. 7,615,545, which is owned by Duramed Pharmaceuticals, Inc., a subsidiary of Teva Pharmaceutical Industries, Ltd.
There are fears in the UK that people who are vulnerable to flu infections may well have to wait for their annual injection this season.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ioannis Papayannis, MD Po Box 33932, Shreveport, LA 71130-3932 Ph: (318) 675-5982 | Dr Ioannis Papayannis, MD 4800 S Hazel St, Pine Bluff, AR 71603-6860 Ph: (870) 534-5533 |
News Archive
Smokeless tobacco and, more recently, e-cigarettes have been promoted as a harm reduction strategy for smokers who are "unable or unwilling to quit."
Transdel Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced positive top-line clinical results for its lead pain drug Ketotransdel®( )in a Phase 3 trial which evaluated the efficacy and safety of the drug in acute soft tissue injuries of the upper and lower extremities.
An ultrafast, 320-detector computed tomography scanner that shows both anatomy within coronary arteries and blood flow can accurately sort out which people need - or don't need - an invasive procedure to identify coronary blockages, according to an international study. The researchers say their findings could potentially save millions of people worldwide from having an unnecessary cardiac catheterization.
Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its levonorgestrel and ethinyl estradiol (0.10 mg/0.02 mg) oral contraceptive product prior to the expiration of U.S. Patent No. 7,615,545, which is owned by Duramed Pharmaceuticals, Inc., a subsidiary of Teva Pharmaceutical Industries, Ltd.
There are fears in the UK that people who are vulnerable to flu infections may well have to wait for their annual injection this season.
› Verified 3 days ago
Mr. James Steven Cash, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1710 W 42nd Ave, Pine Bluff, AR 71603 Phone: 870-535-4400 Fax: 870-535-4447 | |
Dr. Mervin Dale Terrell, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 1220 W 42nd Ave, Pine Bluff, AR 71603 Phone: 870-541-0013 Fax: 870-541-0014 | |
Dr. Brandi Pauline Wright, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 1420 W 43rd Ave Ste A, Pine Bluff, AR 71603 Phone: 870-541-6020 Fax: 870-541-6021 | |
Naznin Jamal, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1600 W 40th Ave, Pine Bluff, AR 71603 Phone: 870-541-7100 | |
Syed Sheheryar Ahmed Shah, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1420 W 43rd Ave Ste A, Pine Bluff, AR 71603 Phone: 870-541-6020 Fax: 870-541-6021 | |
James Trice, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7005 S Hazel St, Pine Bluff, AR 71603 Phone: 870-536-3070 Fax: 870-536-3171 |